| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000028061 |
| Receipt No. | R000032131 |
| Official scientific title of the study | Exploratory test on the influence of yogurt intake on postprandial blood glucose level |
| Date of disclosure of the study information | 2017/07/04 |
| Last modified on | 2017/09/20 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Exploratory test on the influence of yogurt intake on postprandial blood glucose level | |
| Title of the study (Brief title) | Exploratory test on the influence of yogurt intake on postprandial blood glucose level | |
| Region |
|
|
| Condition | ||
| Condition | Healthy Adults | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Explore the effect of yogurt intake on postprandial blood glucose levels. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Blood glucose (AUC, Cmax, C) |
| Key secondary outcomes | Myo-inositol |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Cross-over |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 4 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Rice 150 g | |
| Interventions/Control_2 | Salad 101 g and rice 138 g (salad first) | |
| Interventions/Control_3 | Rice 120 g and yogurt 200 g (rice first) | |
| Interventions/Control_4 | Yogurt 200 g and rice 120 g (yogurt first) | |
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1. Persons who received a sufficient explanation of the purpose and contents of the exam, have the capacity to consent, applied with free will with sufficient understanding, and agreed to participate with a written document
2. Healthy Japanese who is 20 years old or more and under 50 years old 3. Persons whose BMI is 30 or less 4. Persons who do not have impaired glucose tolerance in the past one year examination 5. Persons who are not taking drugs such as anti-hypertensive agents 6. Persons who consume yogurt for less than 2 days per week |
|||
| Key exclusion criteria | 1. Persons who are allergic to the test food
2. Persons who have participated in other tests within the first month before the start of the test, or those who intend to participate in another exam after consenting to this exam 3. Persons who are breastfeeding, pregnant, planning or hoping to be pregnant during the study period 4. Persons who were judged as inappropriate for subjects by the principal investigator |
|||
| Target sample size | 20 | |||
| Research contact person | |
| Name of lead principal investigator | Hirohito Ishikawa |
| Organization | Healthcare Systems Co., Ltd. |
| Division name | Research and Development |
| Address | Nisshin Tatemono Shinbashi Bld. 7F, 4-6-15 Shinbashi, Minato-ku, Tokyo, JAPAN |
| TEL | 03-6809-2722 |
| ishikawa@hc-sys.jp | |
| Public contact | |
| Name of contact person | Hirohito Ishikawa |
| Organization | Healthcare Systems Co., Ltd. |
| Division name | Research and Development |
| Address | Nisshin Tatemono Shinbashi Bld. 7F, 4-6-15 Shinbashi, Minato-ku, Tokyo, JAPAN |
| TEL | 03-6809-2722 |
| Homepage URL | |
| ishikawa@hc-sys.jp | |
| Sponsor | |
| Institute | Healthcare Systems Co., Ltd. |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Japan Diet Laboratory |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000032131 |